Dr Agarwals Health Care Ltd
Incorporated in 2010, Dr. Agarwal's Health Care Limited provides a wide spectrum of eye care services and the retailing of optical products, contact lenses, accessories, and eye care-related pharmaceuticals.[1]
- Market Cap ₹ 13,033 Cr.
- Current Price ₹ 413
- High / Low ₹ 464 / 366
- Stock P/E 835
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 7.71 %
- ROE 1.74 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 22.2% CAGR over last 5 years
Cons
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -5.38%
- Company has a low return on equity of 4.87% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| 202 | 248 | 232 | 362 | 598 | 835 | |
| 186 | 202 | 199 | 275 | 436 | 611 | |
| Operating Profit | 16 | 46 | 33 | 86 | 162 | 224 |
| OPM % | 8% | 19% | 14% | 24% | 27% | 27% |
| 5 | 9 | 4 | 10 | -12 | 38 | |
| Interest | 20 | 42 | 34 | 38 | 64 | 88 |
| Depreciation | 21 | 49 | 55 | 59 | 92 | 129 |
| Profit before tax | -20 | -36 | -52 | -1 | -6 | 45 |
| Tax % | 0% | 0% | 4% | 55% | -641% | 47% |
| -20 | -36 | -54 | -1 | 32 | 24 | |
| EPS in Rs | ||||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 33% |
| 3 Years: | 53% |
| TTM: | 40% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 32% |
| TTM: | -73% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -1% |
| 3 Years: | 5% |
| Last Year: | 2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 8 | 9 |
| Reserves | 290 | 248 | 194 | 192 | 554 | 1,218 |
| 135 | 142 | 161 | 252 | 590 | 661 | |
| 60 | 200 | 281 | 242 | 236 | 298 | |
| Total Liabilities | 492 | 596 | 643 | 692 | 1,388 | 2,187 |
| 99 | 322 | 387 | 367 | 907 | 1,302 | |
| CWIP | 1 | 3 | 11 | 2 | 35 | 9 |
| Investments | 238 | 146 | 121 | 147 | 187 | 629 |
| 154 | 124 | 124 | 176 | 258 | 248 | |
| Total Assets | 492 | 596 | 643 | 692 | 1,388 | 2,187 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| 40 | 46 | 78 | 153 | 222 | ||
| -37 | -26 | -98 | -436 | -818 | ||
| -60 | -21 | 40 | 316 | 570 | ||
| Net Cash Flow | -56 | -1 | 20 | 33 | -26 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| Debtor Days | 46 | 46 | 39 | 31 | 24 | 22 |
| Inventory Days | 138 | 159 | 147 | 149 | 119 | 135 |
| Days Payable | 330 | 427 | 608 | 456 | 354 | 383 |
| Cash Conversion Cycle | -147 | -222 | -422 | -276 | -210 | -226 |
| Working Capital Days | 14 | -30 | -39 | -30 | -45 | -33 |
| ROCE % | 1% | -5% | 9% | 10% | 8% |
Documents
Announcements
-
Commencement Of Operations Of A New Branch
1d - Commencement of operations at new branch in Karnataka.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
1d - Transcript of Q3 FY25 earnings call released.
-
Commencement Of Operation Of A New Branch
19 Feb - Commencement of operation of a new branch in RS Pura.
-
Announcement under Regulation 30 (LODR)-Credit Rating
17 Feb - Crisil reaffirms A+ Stable rating for debt facilities.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
17 Feb - Audio recording of earnings call available.
Concalls
-
Feb 2025Transcript PPT REC
Largest Eyecare Service Provider[1]
Dr. Agarwal is India's largest eye care service chain with a 25% market share. It is the largest company by revenue in FY23, with more than two times the revenue from operations of the second-largest eye care service chain in the country.